1. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods;Aldridge;Environ. Health Perspect.,2003
2. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon;Amitai;Biochem. Pharmacol.,1998
3. ATSDR (Agency for Toxic Substances and Disease Registry), 1997. Toxicological Profile for Chlorpyrifos. U.S. Department of Health & Human Services, Public Health Service, Atlanta, GA.
4. Barker, M.H., 1989. Chlorpyrifos oral toxicity study in Beagle dogs (repeated daily dosage for 13 weeks. Unpublished report from Huntingdon Research Centre, Ltd. England. Study No. MBS 31/88999, May 3, 1989. MRID No. 42172801.
5. Reference dose (RfD): description and use in health risk assessments;Barnes;Reg. Toxicol. Pharm.,1988